We therefore evaluated the effect of EFL3 on the proliferation of RA FLSs by CCK-8 assays, and the data showed that treatment with EFL3 did not obviously disturb the viability of RA FLSs (Figure 2(a)). The gene discussed is EFNB1; the disease is rheumatoid arthritis.